Benzonatate
- Product NDC
- 70934-884
- 11-digit product format
- 709340884
- Labeler code
- 70934
- Product ID
- 70934-884_c9d864fd-24ff-05b2-e053-2995a90a8a1f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Benzonatate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA206948
- Marketing category
- ANDA
- Marketing start
- 2021-08-18
- Marketing end
- 2024-11-30
- Substance
- BENZONATATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-884-20 | 70934088420 | 20 CAPSULE in 1 BOTTLE, PLASTIC (70934-884-20) | 20 capsule | 2021-10-01 | 2024-10-31 | No | No | Current |
| 70934-884-30 | 70934088430 | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-884-30) | 30 capsule | 2021-08-18 | 2024-11-30 | No | No | Current |